Skip to content
Tuesday 11 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,869.26
+0.06%
DAX
26,313.63
-0.04%
CAC 40
8,712.17
-0.16%
STOXX 50
6,543.57
+0.12%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Wednesday 29 April 2026 11:03 am  |  Updated:  Wednesday 29 April 2026 11:04 am

Frontier Scientific Solutions Appoints Michelle D’Angelo as Chief Commercial Officer

Frontier Scientific Solutions (“Frontier”), a leading provider of cGMP-compliant, temperature-controlled logistics solutions, today announced the appointment of Michelle D’Angelo as Chief Commercial Officer (CCO). D’Angelo brings over 25 years of experience in the pharmaceutical and biotechnology CDMO sector, with deep expertise in commercial leadership, business development, and customer engagement.

D’Angelo has built her career working closely with global life sciences organizations to address complex development and supply chain challenges. She has led commercial initiatives that enhance customer experience while driving sustained business growth, combining strategic vision with a hands-on approach to execution.

“Michelle brings a powerful combination of commercial acumen and deep industry experience,” said Steve Uebele, CEO of Frontier Scientific Solutions. “Her track record translating customer insight into impactful growth strategies will be instrumental as we continue to scale our platform and strengthen our partnerships across the life sciences sector.”

In her role as Chief Commercial Officer, D’Angelo will lead Frontier’s global commercial strategy, including sales and marketing functions, ensuring alignment with evolving client needs and market dynamics. She will play a key role in advancing Frontier’s mission to deliver integrated, end-to-end logistics solutions purpose-built for the life sciences industry and the organizations that support it.

“Frontier is addressing one of the most critical challenges in the life sciences industry, ensuring the safe, compliant, and efficient movement of temperature-sensitive therapies,” said D’Angelo. “I am excited to join the team at this important stage of growth and to help expand our commercial capabilities in support of our clients’ evolving needs.”

As Frontier Scientific Solutions continues to expand its global network, D’Angelo’s appointment reflects the company’s continued investment in leadership to support its long-term growth strategy across the life sciences sector. That strategy is centered on delivering a differentiated, life sciences-focused network designed to support the evolving needs of the pharmaceutical and biotech industries, helping ensure temperature-controlled, critical, and life-changing therapies reach patients safely, securely, and without compromise.

About Frontier Scientific Solutions
Frontier Scientific Solutions is a dedicated global logistics integrator built exclusively for life sciences. The company operates cGMP‑validated, temperature‑controlled facilities with direct runway access, leverages Free Trade Zones to streamline cross‑border movement, and runs flights dedicated only to life sciences materials. Frontier’s model reduces touchpoints and transit time to promote zero losses, directly supporting patient access to critical medicines.

Michelle D’Angelo appointed Chief Commercial Officer at Frontier Scientific Solutions, driving growth amid global expansion

View source version on businesswire.com: https://www.businesswire.com/news/home/20260429192000/en/

Contact

Media Contact
Zachary Dembner
BerlinRosen
[email protected]

Company Logo
Company Logo
Read more

ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Businesswire

Categories

  • Personnel

Trending Articles

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Hargreaves Lansdown orders staff back to office

  • As it happened: Intel, Arm shares slide; Oil climbs higher

More from Morning Wire

  • ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

    Business Wire
  • Cognita Reply Named an OpenAI Advanced Partner to Accelerate Enterprise Adoption of Frontier AI

    Business Wire
  • Ohmium Appoints Hydrogen Veteran as Chief Commercial Officer

    Business Wire
  • MEX Exchange, Part of MultiBank Group Strengthens Leadership Team with Key Appointment

    Business Wire
  • CG Semi Commences Commercial Production at Its G1 OSAT Facility in Sanand, Gujarat

    Business Wire
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
  • Convertr Appoints Greg Jordan as Chief Product Officer to Strengthen Data Governance for Enterprise B2B Programmes

    Business Wire
  • Footprint Expands Into PE-Free Cups, Bringing a Proven, Recyclable and Home-Compostable Alternative to Plastic-Lined Paper Cups Into Production

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook